Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis

#KrystalBiotech Receives #FDAPlatformTechnologyDesignation for HSV-1 Viral Vector Used in KB801 for the Treatment of #NeurotrophicKeratitis

KB801 has the potential to significantly reduce treatment burden & maintain consistent NGF levels.

www.biospace.com/press-releas...

Farmaci, Prix Galien Italia a Krystal Biotech per la prima terapia genica in una malattia rara (Adnkronos) - Krystal Biotech ha annunciato di aver ricevuto il prestigioso Prix Galien Italia 2025 nella categoria Medicinali per terapia avanzata (Atmp) per Vyjuvek® (beremagene geperpavec o B-vec), la prima e unica terapia genica ap...

Farmaci, Prix Galien Italia a Krystal Biotech per la prima terapia genica in una malattia rara ... LEGGI TUTTO #Farmaci #PrixGalien #KrystalBiotech #TerapiaGenica #MedicinaAvanzata